The information requested and provided does not present very well as text, which is why it was attached as original files. We assure you the files provided have been scanned for viruses
We have pasted the content below if you remain concerned, however we would stress that it is much more accessible in the format provided in the attachments.
25/06/25
FOI Reference 25/26-1789 ECT/Restraints/Seclusion/Medication errors
Please provide Electro Convulsive Treatment (ECT) information under the FOI act to the following questions: -
1.Please supply patient’s information ECT leaflet Attached
2.Please supply patient ECT consent form Attached
3.Please supply any ECT reports/investigations Commented [PA1]: I am assuming this is blank as we don’t have any? Please can we check and/or put N/A Commented [CS2R1]: Correct N/A
4.How many ECT in 2024? 93 courses
5.What proportion of patients were men/women? Men 30 Women 63
6.How old were they? We are unable to provide this information as this is exempt under Section 40 of the Act (personal information)
7.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")? 2%
8.How many people covered by the equality act - specific protected characteristics - excluding age + gender - received ECT ? All our patients who receive treatment have characteristics protected by the Equalities Act.
9.How many people were offered talking therapy prior to ECT ? All patients for whom talking therapy is indicated are offered this prior to receiving ECT.
10.How many were receiving ECT for the first time? 26 patients
11.How many patients consented to ECT? 41 patients
12.How many ECT complaints were investigated outside the NHS ? None
13.How many patients died during or 1 month after ECT and what was the cause (whether or not ECT was considered the cause)? We are unable to provide reliable information as we may not be informed of any such deaths.
14.How many patients died within 6 months after ECT and what was the cause (whether or not ECT was considered the cause)? As above Q13
15.How many patients died by suicide within 6 months of receiving ECT (whether or not ECT was considered the cause)? As above Q13
16.How many patients have suffered complications during and after ECT and what were those complications? We cannot give details on individual cases due to confidentiality.
17.Have there been any formal complaints from patients/relatives about ECT? No
18.If so, what was their concerns? N/A
19.How many patients report memory loss/loss of cognitive function? Memory function is routinely assessed, objectively and subjectively, before ECT and after each treatment
20.What tests are used to assess memory loss/loss of cognitive function? Montreal Cognitive Assessment or Mini-Mental State Examination (objective) - CPRS item 17 (subjective).
21.Have MRI or CT scans been used before and after ECT? Yes
22.If so, what was the conclusion? We cannot give details on individual cases due to confidentiality.
23.How does the Trust plan to prevent ECT in the future? There are no plans to prevent ECT, as it is a well-researched successful treatment for the treatment of specific severe mental disorders. Following NICE guidelines ECT is only administered if clinically indicated with informed consent or within the legal framework of the Mental Health Act once all other treatment methods have been considered and or were unsuccessful and considering the risks and benefits for the individual.
Please provide restraints information under the FOI act to the following questions: -
1.Please supply any Restraints/investigations N/A
2.How many RESTRAINTS in 2024? 2,835 - in 2024 there were a small number of patients, due to their complexity of mental health presentation, required multiple restraints to maintain their safety. This has impacted on the proportion of restraints undertake in 2024.
3.What proportion of patients were men/women? Men 783 Women 1988
4.How old were they? We are unable to provide this information as this is exempt under Section 40 of the Act (personal information)
5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")? 182 individuals
6.How many people covered by the equality act - specific protected characteristics - excluding age + gender - were restrained? All our patients who receive treatment have characteristics protected by the Equalities Act.
7.How many RESTRAINTS were investigated outside the NHS? We do not have this information
8.How many patients died during or 1 month after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause? We are unable to provide reliable information as we may not be informed of any such deaths.
9.How many patients died within 6 months after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)? As above Q8
10.How many patients died by suicide within 6 months of receiving RESTRAINTS (whether or not RESTRAINTS was considered the cause)? As above Q8
11.How many patients have suffered complications during and after RESTRAINTS and what were those complications? Exempt under Section 12 of the Freedom of Information Act 2000 as obtaining this information would entail a manual check of individual patient records which would be outside the scope of the Act.
12.Have there been any formal complaints from patients/relatives about RESTRAINTS? Yes
13.If so, what was their concerns? We cannot give details on individual cases due to confidentiality.
14.Are counts of forced injections available? if so how many people were forcible injected ? This is not a term used by the Trust
15.How does the Trust plan to reduce restraints in the future? The Trust has a Restraint Reduction Specialist and a lead nurse for standards and quality. Plan is to review the Reducing restrictive intervention strategy, using key data set to identify key actions required.
16.How many of these restraints were face down restraints? 336
Please provide SECLUSION information under the FOI act to the following questions: -
1.Please supply any SECLUSION reports/investigations
2.How many SECLUSIONS in 2024? 298
3.What proportion of patients were men/women? Men 206 Women 90
4.How old were they? We are unable to provide this information as this is exempt under Section 40 of the Act (personal information)
5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")? 44 individuals
6.How many people covered by the equality act - specific protected characteristics - excluding age + gender - were secluded ? All our patients who receive treatment have characteristics protected by the Equalities Act.
7.How many SECLUSIONS were investigated outside the NHS? We do not have this information
8.How many patients died during or 1 month after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)? We are unable to provide reliable information as we may not be informed of any such deaths.
9.How many patients died within 6 months after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)? As above Q8
10.How many patients died by suicide within 6 months of receiving SECLUSION (whether or not SECLUSION was considered the cause)? As above Q8
11.How many patients have suffered complications during and after SECLUSION and what were those complications? Exempt under Section 12 of the Freedom of Information Act 2000 as obtaining this information would entail a manual check of individual patient records which would be outside the scope of the Act.
12.Have there been any formal complaints from patients/relatives about SECLUSION? We do not report on this centrally so we are unable to provide this information
13.If so, what was their concerns? As above Q12
14.How does the Trust plan to reduce SECLUSIONS in the future? The Trust has a Restraint Reduction Specialist and a nurse for standards and quality. Plan is to review the Reducing restrictive intervention strategy (to include management of seclusion), using key data set to identify key actions required.
Please provide MEDICATION ERRORS information under the FOI act to the following questions: Note: Improved categorisation and reporting practices, as well as a broader emphasis on capturing patient adherence issues such as non-compliance with medication has increased medication incidents reported since 2023. Additionally, there were increases in near-miss reporting and documentation-related categories such as "Incorrect Storage - Near Miss" and "Prescription Pad Missing," suggesting enhanced vigilance and safety culture across services
1.Please supply any MEDICATION ERRORS reports/investigations
2.How many MEDICATION ERRORS in 2024? 1395
3.What proportion of patients were men/women? Men 531 Women 723
4.How old were they? We are unable to provide this information as this is exempt under Section 40 of the Act (personal information)
5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")? 55 individuals
6.How many people covered by the equality act - specific protected characteristics - excluding age + gender - endured medication errors ? All our patients who receive treatment have characteristics protected by the Equalities Act.
7.How many MEDICATION ERRORS were investigated outside the NHS? We do not have this information
8.How many patients died during or 1 month after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)? We are unable to provide reliable information as we may not be informed of any such deaths.
9.How many patients died within 6 months after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)? As above Q8
10.How many patients died by suicide within 6 months of receiving MEDICATION ERRORS (whether or not MEDICATION ERRORS was considered the cause)? As above Q8
11.How many patients have suffered complications during and after MEDICATION ERRORS and what were those complications? Exempt under Section 12 of the Freedom of Information Act 2000 as obtaining this information would entail a manual check of individual patient records which would be outside the scope of the Act.
12.Have there been any formal complaints from patients/relatives about MEDICATION ERRORS? Yes
13.If so, what was their concerns? We cannot give details on individual cases due to confidentiality.
14.How does the Trust plan to prevent MEDICATION ERRORS in the future? The Medicines Safety Officer role will continue to develop effective processes for reviewing medicines related errors and systems, taking actions to identify learning through improvements in data from our electronic systems and to be better at proactively preventing them from reoccurring. There will also be the development and implementation of a medicines safety strategy that includes:
- The reinforcement of ensuring patients are informed, engaged and involved in shared decision making about their medicines. This includes educating them about their medicines, ensuring access to information resources, and improving digital literacy around medicines for patients who prefer to access information in this way.
- Development of an integrated Electronic Prescribing and medicines administration system. This will improve how we reconcile medicines, enhance communication of prescribed medicines, aid in the choice of medicines prescribed and reduce prescribing and administration errors. The system will also incorporate clinical decision support that will improve the way that medicines are initially prescribed. This system has been procured as part of an electronic patient record project.
- Development of an organisational approach to deploying automated and barcoding technologies that enable safer selection and administration of medicines.
- Improving our medicines safety culture through the application of safety science, systems thinking, Just culture and the application of the patient safety incident response framework within investigations. This includes consideration for environmental factors like minimising interruptions, and ensuring adequate staffing.
- Continue to participate in national and integrated care systems networks and alliances to build communication channels between medicines safety officers and expert clinical leads that bridge clinical and pharmacy services between providers. This aids sharing and learning from incidents and the development of best practice models and initiatives.
- Utilising a recent restructuring within the pharmacy team to bolster support within the organisation in medicines safety leadership. This enables teams to be invited to reflect on learning from medicines safety events and to continue to engage and look for new ways to improve safety and effectiveness. This is co-ordinated centrally so that the medicines errors are shared widely and processes and systems are developed with organisational
oversight such as identifying common themes in incidents and errors and the standardising of procedures to prevent them.
ECT consent form:
Electroconvulsive Therapy (ECT) Consent Form (FORM 1) Page 1 of 2
FORM 1
PATIENT CONSENT TO ELECTROCONVULSIVE THERAPY (ECT)
First name ..………..…...........………... Surname (family name) ...…..……………..….…….
Date of birth ……………………………. CIS No. (or other identifier) …....……...……….…….
Consultant Psychiatrist ……......……………………………………………………………...
Gender: Male Female Other …………………………...
Special requirements ………….………………………………………………………………
(e.g. other language / communication method)
NAME OF PROPOSED PROCEDURE / COURSE OF TREATMENT
A course of up to twelve Electroconvulsive Therapy (ECT) treatments.
STATEMENT OF DOCTOR
(to be completed by the consultant psychiatrist, or a doctor under his/her supervision with
appropriate knowledge of the proposed procedure, as specified in the Trust’s consent policy)
I have explained the procedure to the patient. In particular, I have explained:
The intended benefits: (tick whichever applies)
- a reduction in symptoms (for an acute course)
- prevention of relapse or recurrence (for continuation or maintenance treatment)
Frequently occurring, transient side effects:
- muscle aches
- headache
- confusion
- short-term memory loss (anterograde amnesia)
Less common side effects:
- dental damage
- autobiographical memory loss (retrograde amnesia)
I have also discussed what the procedure is likely to involve, the benefits and risks of any available alternative treatments (including no treatment) and any particular concerns of this patient. I have explained that the procedure will involve general anaesthesia and muscle relaxation.
An ECT information leaflet has been provided to the patient.
Signed: ………………………. Name (PRINT) ………………………..……… Date ……..……
Position: ……………………… Contact details (if patient wishes to discuss options later) …………... Electroconvulsive Therapy (ECT) Consent Form (FORM 1) Page 2 of 2
STATEMENT OF INTERPRETER (where appropriate)
I have interpreted the information above to the patient to the best of my ability and in a way which I believe the patient can understand.
Signed: ………………………. Name (PRINT) ………………………..……… Date ……..……
STATEMENT OF PATIENT
This document is available in other formats on request, such as large print, electronically or another language. Please call 0300 304 0664.
Please read this form carefully.
If the procedure has been planned in advance, you should have had an information leaflet, which describes the benefits and risks of ECT. If not, you will be offered a copy now. If you have any further questions, do ask – we are here to help you. You have the right to change your mind at any time, including after you have signed this form.
I agree to the procedure and course of treatment described on this form.
I understand that you cannot give me a guarantee that a particular person will perform the procedure. The person will, however, have appropriate experience.
I understand that I will have the opportunity to discuss the details of anaesthesia with an anaesthetist before the procedure, unless the urgency of my situation prevents this.
I understand that any procedure in addition to those described on this form will only be carried out if it is necessary to save my life or to prevent serious harm to my health.
I understand that, after receiving treatment, there must be an adult with me for the remainder of the day and night.
I understand that, on the day of receiving treatment, I must not drink alcohol, operate heavy machinery, drive or sign legal documents.
I have been told about additional procedures which may become necessary during my treatment. I have listed below any procedures which I do not wish to be carried out without further discussion.
…………………………………………………………………………………………………...…
………………………………………………………….........................................................…
Signed: ………………………. Name (PRINT) ………………………..……… Date ……..……
STATEMENT OF WITNESS (where appropriate)
A witness should sign below if the patient is unable to sign but has indicated his or her consent. Young people / children may also like a parent to sign here (see notes).
Signed: ………………………. Name (PRINT) ………………………..……… Date ……..……
ECT leaflet:
Electroconvulsive therapy
(ECT)
This information is for anyone who is considering whether to have
electroconvulsive therapy and their families or friends.
You and your doctors need to be sure that you are fully informed when making a
decision about whether to have ECT or not. Your doctor will talk to you about this.
We hope that this information can support you in making this decision by providing
information on:
🔵 what ECT is and why it is used
🔵 what is involved in having ECT
🔵 the benefits of ECT
🔵 the risks and potential side effects of ECT
🔵 what might happen if you do not have ECT
🔵 making decisions about having ECT
🔵 where to find further information.
Disclaimer
This resource provides information, not advice.
The content in this resource is provided for general information only. It is not intended
to, and does not, amount to advice which you should rely on. It is not in any way an
alternative to specific advice.
You must therefore obtain the relevant professional or specialist advice before taking,
or refraining from, any action based on the information in this resource.
If you have questions about any medical matter, you should consult your doctor or
other professional healthcare provider without delay.
If you think you are experiencing any medical condition, you should seek immediate
medical attention from a doctor or other professional healthcare provider.
Although we make reasonable efforts to compile accurate information in our resources
and to update the information in our resources, we make no representations,
warranties or guarantees, whether express or implied, that the content in this resource
is accurate, complete or up to date.
1
What is ECT and why is it used?
ECT is an effective treatment for some types of severe mental illness. It is usually
considered when other treatment options, such as psychotherapy or medication, have
not been successful or when someone is very unwell and needs urgent treatment.
ECT is given as a course of treatments, typically twice a week for 3–8 weeks. If you have
ECT, it will take place under general anaesthetic. This means that you will be asleep
while it happens.
While you are asleep, your brain will be stimulated with short electric pulses. This
causes a fit which lasts for less than two minutes. As well as an anaesthetic, you will be
given a muscle relaxant which reduces how much your body moves during the fit.
What conditions can ECT be used for?
ECT is most commonly used for severe depression that hasn’t responded to other
treatments. It is also used to treat catatonia, an uncommon condition in which a
patient may stop talking, eating or moving. Occasionally, it is used to treat people in
the manic phase of bipolar disorder or when people have mixed symptoms of both
mania and depression.
ECT is not advised for the treatment of anxiety disorders or most other psychiatric
conditions. In the medium term, ECT can help the symptoms of schizophrenia that
have not improved with medication. However, the long-term benefits, which require
continued ECT, are less clear. For this reason, it is not often used in the UK.
When might your doctor suggest ECT?
ECT will usually be suggested if your condition:
🔵 is life-threatening and you need to get better quickly to save your life
🔵 is causing you immense suffering
🔵 has not responded to other treatments, such as medication and psychological
therapy or
🔵 has responded well to ECT in the past
How effective is ECT?
Doctors treating people with ECT report that most people see an improvement in
their symptoms. In 2018-2019, 68% of people who had been treated with ECT were
“much-improved” or “very much improved” at the end of treatment (1,361 courses
out of a total of 2,004). Some of these people were reported as showing no change in
their condition and for a very small number of people (1%) it was reported that their
condition was worse.
2
Treating depression
A large body of evidence shows that ECT is more successful in treating the most severe
cases of depression than any other treatments that it has been compared to. These
include:
🔵 antidepressants
🔵 placebos - where someone is given a substance or procedure that has no physical
effect to test the effectiveness of new treatments
🔵 neuromodulation treatments such as Transcranial Magnetic Stimulation (rTMS).
The risk of suicide is lower in people who have ECT than in comparable people who do
not.
Staying well
ECT can help people who are very unwell to get better enough to have other kinds of
treatments. This can help them stay well for longer.
Research suggests that people who have severe depression that hasn’t got better with
medication are much more likely to get better and stay well for longer if they have
ECT.
Of people who get better after having ECT, half of them will stay well for at least
a year. This is more likely if they are given a treatment after they finish ECT, like
antidepressants or lithium.
In comparison, people with severe depression that hasn’t got better after they have
tried two different antidepressants have only a 5% chance of getting better and
staying well for at least a year if they are given a third antidepressant.
How does ECT work?
The effects of ECT gradually build with each treatment. ECT causes the release of
certain brain chemicals, which seem to stimulate the growth of some areas in the
brain that tend to shrink with depression.
ECT also appears to change how parts of the brain which are involved in emotions
interact with each other. There is ongoing research in this area to help us to
understand more about how ECT works.
Are there different types of ECT?
ECT has changed and developed over the years. For example, the amount and form of
electricity used has changed. This has reduced the chance of side-effects.
ECT is given in two ways: bilateral ECT and unilateral ECT. Your doctor will be able to
explain more and help to advise you on which type of ECT would suit you better.
With bilateral ECT the stimulating electrical pulses pass across your head, between
your temples. With unilateral ECT, they pass between your right temple and the top
of your head. Bilateral ECT may work more quickly, while unilateral ECT has less of
3
an effect on memory. There is further information about side effects later on in this
resource.
Can ECT be used in children or young people?
ECT is not used in children under the age of 11. Children between 11 and 18 rarely
develop the kind of mental illnesses that respond well to ECT, but for a small number
who do, ECT can be helpful. A formal, independent second opinion is required before it
can be given.
What happens when you have ECT?
ECT is given in hospital and usually takes place in a set of rooms called the ‘ECT suite’.
Occasionally, if this is unavailable or you have significant physical health problems,
treatment might take place in another hospital with more medical support, or in an
operating theatre.
Some people having ECT are inpatients in hospital, while others will have ECT as day
patients. If you are a day patient, a named, responsible adult will have to accompany
you to and from the ECT suite.
An ECT suite should have a room where you can wait, a room where you have your
treatment, and a room where you can recover properly before leaving.
Qualified staff will look after you all the time you are there. They can help answer any
questions or concerns you might have before you have the treatment. They will also
help you with the process of waking up from the anaesthetic and during the time
straight after the treatment.
Preparing for ECT
In the days before your course of ECT is started, your doctor will arrange for some
tests to make sure it is safe for you to have a general anaesthetic. These may include a
record of your heartbeat (ECG) and blood tests.
You must not eat or drink anything for at least 6 hours before ECT, although you may
be allowed to drink sips of water up to 2 hours beforehand. This is so you can have the
anaesthetic safely.
If you would usually take medication during this time, ask the ECT team for advice on
whether you should still do this.
What happens on the day of your ECT treatment?
🔵 If you are an inpatient, a member of staff will come with you to the ECT suite.
They will know about your illness and can explain what is happening. Many ECT
suites are happy for family members to stay in the waiting room while you have
your treatment.
🔵 You will be met by a member of the ECT staff, who will do routine physical checks
(if they have not already been done).
4
🔵 You will be asked before every treatment about your memory and how good it is.
🔵 If you are having ECT voluntarily staff will check that you are still willing to have it,
and will ask if you have any further questions.
🔵 When you are ready, the ECT staff will take you into the treatment area.
🔵 The staff will connect monitoring equipment to measure your heart rate, blood
pressure, oxygen levels and brain waves.
🔵 You will be given oxygen to breathe through a mask. The anaesthetist will give
you an anaesthetic through an injection into the back of your hand.
What happens while you are asleep?
🔵 While you are asleep, the anaesthetist will give you a muscle relaxant and a
mouth guard will be put in your mouth to protect your teeth.
🔵 Two metal discs will be placed on your head. In bilateral ECT, one goes on each
side of your head, while in unilateral ECT both go on the same side of your head.
🔵 The ECT machine will deliver a series of brief electrical pulses, for three to eight
seconds. This will result in a controlled fit which lasts for an average of 40
seconds, and may last up to 120 seconds. Your body will stiffen and then there will
be twitching, usually seen in your hands, feet and face. The muscle relaxant
reduces how much your body moves.
🔵 The dose of the electric pulses given is based on the amount needed to induce a
fit. Your response will be monitored, and the dose adjusted as necessary.
What happens when you wake up?
🔵 The muscle relaxant will wear off within a couple of minutes. As you are starting
to wake up, staff will take you through to the recovery area. Here, an experienced
nurse will look after you until you are fully awake.
🔵 The nurse will take your blood pressure and ask you simple questions to check
how awake you are. There will be a small monitor on your finger to measure the
oxygen in your blood. You may wake up with an oxygen mask. It can take a while
to wake up fully and, at first, you might not know where you are. After half an
hour or so, these effects should have worn off and you will be asked some simple
questions to check this.
🔵 Most ECT suites have a second area where you can sit and have a cup of tea or
some other light refreshment. You will leave the ECT suite when your physical
state is stable, and you feel ready to do so.
🔵 The whole process usually takes about an hour.
In the 24 hours after each treatment, you should not drink alcohol or sign any legal
documents.
You should have a responsible adult with you for 24 hours.
5
How often and how many times is ECT given?
ECT is usually given twice a week, with a few days in between each treatment. It can
take several sessions before you notice an improvement.
It is not possible to predict, in advance, how many treatments you will need. On
average, you will receive 9 or 10 treatments in a course, although it is common to have
more.
If you have had no improvement at all after 6 treatments, your treatment plan will be
reviewed with your doctor to discuss whether to continue or change the form of ECT.
Your medical team will review your progress and any side effects, usually every week.
You will be asked about your memory and it will be tested regularly.
ECT will usually be stopped soon after you have made a full recovery, or if you say you
don’t want to have it anymore and are well enough to understand this decision.
What happens after a course of ECT?
ECT is one part of getting better. It should also help you to begin or restart other
treatments or types of support.
You will usually continue or start medication after ECT. This will help to maintain the
improvements you have had from your ECT treatment.
ECT can sometimes be continued to help stop you from getting unwell again. This is
especially the case if you have previously relapsed after a course of ECT. This is known
as ‘continuation’ or ‘maintenance’ ECT, and is given less often, for example every 2-4
weeks.
Talking therapies such as CBT and counselling can help you to work on any reasons
for your depression and to develop ways of staying well. Changes in your day-today
lifestyle can also be helpful. These include taking regular exercise, eating well,
developing a regular sleep pattern, and using techniques like mindfulness and
meditation.
The ECT clinic or the psychiatrist who arranged the treatment will contact you to
ask about your memory 2 months after your last treatment. If you are experiencing
problems with your memory you can ask to be referred to a neuropsychologist or
memory assessment service for detailed testing.
What are the side effects of ECT?
As with any treatment, ECT can have side effects.
Side effects are usually mild and short term but can sometimes be more severe and
potentially long-lasting.
The risk of side effects is slightly increased if higher doses of stimulating pulses are
needed, if you are a woman or if you are elderly.
If you experience side effects during a course of ECT, the treatment can be adjusted.
6
Short-term side effects
Immediately after ECT, you may experience:
🔵 Headaches
🔵 Aching in the muscles and/or jaw
🔵 Tiredness while the effects of the anaesthetic wear off
🔵 Confusion, particularly if you are elderly. This usually wears off after 30 minutes
🔵 Sickness or nausea
A nurse will be with you while you wake up after ECT. They can also give you simple
pain relief, like paracetamol.
Up to 40% of patients can have temporary memory problems while they are having
ECT. For example, they may forget conversations with visitors during this time.
However, before having ECT about a fifth (17%) of people say that their memory was
already bad enough to be causing them problems. It is difficult to separate out the
effects ECT has on memory from the effects that the illnesses it is treating has on
memory.
In most people, memory difficulties clear within two months of the last treatment and
do not cause problems or distress.
All medical procedures carry risk. If the anaesthetist considers it unsafe to give you an
anaesthetic, you will not be able to have ECT.
People who have been admitted to hospital because of depression are less likely to die
after having ECT than if they do not have ECT. This could be because ECT helps people
recover, or because people who are given ECT receive closer medical attention.
Very rarely, ECT can trigger a prolonged fit. This would be immediately treated by the
medical staff present.
Long-term side effects
The extent of long-term side effects is controversial.
Rigorous scientific research has not found any evidence of physical brain damage in
patients who have had ECT. There is no increased risk of epilepsy, stroke or dementia
after ECT.
The most serious potential long-term side effect of ECT is that you might forget
events from your past. A small number of patients report gaps in their memory about
events in their life that happened before they had ECT. This tends to affect memories
of events that occurred during, or shortly before, the depression started. Sometimes
these memories return fully or partially, but sometimes these gaps can be permanent.
Recent research suggests that 7% of people receiving unilateral ECT report some
persistent memory loss 12 months after ECT.
7
What can happen if you don’t have ECT?
You and your doctor will need to balance the risk of you experiencing side effects from
ECT with the risk of you not having ECT. Not having ECT may mean that you are more
likely to have:
🔵 Prolonged and disabling mental illness
🔵 Serious physical illness (and possibly death) from not eating or drinking
🔵 An increased risk of death from suicide
Driving and ECT
If you are severely ill enough to need ECT you should not be driving. The DVLA advise
that you should not drive during a course of ECT. After you have finished the course,
it may be a little while before you can start driving again. The DVLA, with advice from
your doctor, will make this decision.
If you have continuation or maintenance ECT to help keep you well you can normally
continue to drive. However, you should not drive, ride a bike or operate heavy
machinery for at least 48 hours after each ECT treatment.
Deciding about ECT
Consenting to having ECT
Like any significant treatment in medicine or surgery, you will be asked for your
consent, or permission, to have ECT. The ECT treatment, the reasons for doing it and
the possible benefits and side effects will be explained to you.
If you decide to go ahead, you will be given a consent form to sign. It is a record that
ECT has been explained to you, that you understand what is going to happen, and that
you give your consent to having it. Unless it is an emergency you will be given at least
24 hours to think about this and to discuss it with your relatives, friends or advisors.
You can withdraw your consent at any point, even just before the first treatment. You
should be given information explaining your rights about consenting to treatment.
More information on giving consent to having ECT is available on the Care Quality
Commission (CQC) website.
Can you make your wishes about having ECT known in advance?
If you have feelings about ECT, either for or against, you should tell the doctors and
nurses caring for you. You should also tell friends, family or anyone else you would like
to support you or speak for you. Doctors must consider these views when they think
about whether or not ECT is in your best interests.
If, when you are well, you are sure you would not want ECT if you were to become ill
again, then you may want to write a statement of your wishes. This can be known
8
as an ‘advance decision’ in England, Northern Ireland and Wales, or an ‘advance
statement’ in Scotland. These wishes should be followed except under very specific
circumstances. This is a complicated topic and beyond the scope of this resource.
Some people who have previously been successfully treated with ECT have found it
so helpful that they have recorded ahead of time that they want to have ECT if they
become ill again, even if they say at the time that they do not want it.
Can ECT be given to you without your permission?
If someone has the ‘capacity’ to decide whether or not to have ECT, it cannot be given
without their fully informed consent.
Some people become so unwell they are said to ‘lack capacity’ to make decisions
about ECT. This means they cannot properly understand the nature, purpose or effects
of the treatment, remember this information, or weigh up the pros and cons of having
ECT.
There are laws in the UK that allow doctors to make decisions about giving ECT
treatment to people in this situation. These come with legal safeguards to ensure
treatment is only given if it is absolutely necessary.
This is the case for around half of people who receive ECT treatment. People who have
ECT in this way do just as well as those who have been able to give consent.
When someone gets better and ‘regains capacity’ their consent must be sought again.
Further information about consent and ECT can be found on the CQC website.
How is the quality of ECT in your hospital
assessed?
The ECT Accreditation Service (ECTAS) is a voluntary network of mental health services
in England, Wales and Northern Ireland that promotes best practice in ECT treatment.
The network helps to improve quality of care by supporting ECT clinics to meet a set of
agreed standards, such as on safety and legal issues.
The Scottish ECT Accreditation Network (SEAN) performs a similar function and covers
every ECT service in Scotland.
ECTAS and SEAN are not the statutory regulators of ECT services. This is the
responsibility of the Care Quality Commission in England, the Healthcare Inspectorate
Wales in Wales, Healthcare Improvement Scotland in Scotland and the Regulation and
Quality Improvement Authority in Northern Ireland.
Where can you get more information?
You can find out more information via the links below:
🔵 healthtalk.org resource on ECT
🔵 MIND information on ECT
🔵 Rethink Mental Illness factsheet on ECT
9
Further reading
National Institute for Health and Care Excellence (NICE)
🔵 Guidance on the use of electroconvulsive therapy. Technology appraisal guidance [TA59].
🔵 Depression in adults: recognition and management. Clinical guideline [CG90].
🔵 The use of electroconvulsive therapy: Understanding NICE guidance – information for
service users, their advocates and carers, and the public (PDF).
🔵 Scottish ECT Accreditation Network (SEAN)
🔵 Electroconvulsive Therapy Accreditation Services (ECTAS)
Acknowledgements
This information was produced by the Royal College of Psychiatrists’ Public Engagement
Editorial Board (PEEB). It reflects the best available evidence at the time of writing.
Expert review and contributors:
🔵 Committee on ECT and Related Treatments
🔵 Electroconvulsive Therapy Accreditation Service (ECTAS)
🔵 Scottish ECT Accreditation Network (SEAN)
🔵 Professor Wendy Burn, Immediate Past President and Chair of PEEB
This information was revised in March 2022
© March 2022 Royal College of Psychiatrists
10
From: FOI (SUSSEX PARTNERSHIP NHS FOUNDATION TRUST) <spft.foi@nhs.net>
Sent: 07 July 2025 12:53
To: mrs.wendy.micklewright <mrs.wendy.micklewright@proton.me>
Subject: RE: FRREDOM OF INFORMATION REQUEST 2024 FOI 25.26-1789
Dear Mrs Micklewright
Thank you for your enquiry requesting information under the Freedom of Information Act 2000 and apologies for the delay in getting back to you.
Please find our response to your request attached.
The information supplied to you continues to be protected by copyright. You are free to use it for your own purposes, including for private study and non-commercial research, and for any other purpose authorised by an exception in current copyright law. Documents (except photographs) can be also used in the UK without requiring permission for the purposes of news reporting. Any other reuse, for example commercial publication, would require the permission of the copyright holder.
RE-USE OF INFORMATION
To comply with the Re-use of Public Sector Information Regulations (2015), this information is provided to you under the Open Government Licence (OGL). This licence does not grant you any right to use the Information in a way that suggests any official status or that Sussex Partnership NHS Foundation Trust endorses you or your use of the Information. The re-use of this information indicates your acceptance of the terms and conditions as set out in the Open Government Licence.
When you use our information under the OGL, you should include the following attribution:
Sussex Partnership NHS Foundation Trust 2022, licensed under the Open Government License.
If you wish to re-use information outside of the licence terms then please inform the Trust, as unauthorised re-use may be in breach of copyright law. For information where the copyright is owned by another person or organisation, you must apply to the copyright owner to obtain their permission to re-use.
FURTHER QUERIES
Should you have any general questions, please don’t hesitate to contact me directly by email at FOI@spft.nhs.uk.
If you are unhappy with the way in which your request has been handled, the Trust has an internal review procedure through which you can raise any concerns you might have. A request for an internal review should be submitted in writing to the FOI Team at the above address or by email to FOI@spft.nhs.uk.
If you are dissatisfied with the outcome of the internal review procedure, you can appeal to the Information Commissioner, who will consider whether the Trust has complied with its obligations under the Act, and can require the Trust to remedy any problems.
You can find out more about how to do this, and about the Act in general, on the Information Commissioner’s website at: www.ico.org.uk.
Complaints to the Information Commissioner should be sent to:
First Contact Team
Information Commissioner’s Office
Wycliffe House
Water Lane
Wilmslow
Cheshire
SK9 5AF
Sussex Partnership NHS Foundation Trust is dedicated to looking after all personal data. Information on how the Trust collects, uses and shares this information is available on our privacy notice here.
Please remember to quote our FOI reference number which can be found at the top of this letter in any future correspondence.
I do hope you find the information provided helpful.
Regards
Liz Hecker
Liz Hecker
Freedom of Information (FOI) Officer
Information Governance Team
Sussex Partnership NHS Foundation Trust